Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $779.84 million as of June 27, 2025. Its market cap has increased by 341.09% in one year.

Market Cap

779.84M

Enterprise Value

782.82M

Revenue

70.00M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.71

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 779.84M, an increase of 8,044.34%. That is a compound annual growth rate of 17.74%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	779.84M	34.91%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	52.63M	-31.72%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
American Oncology Network	420.90M
CytoDyn	404.64M
Glass House Brands	389.15M
Northwest Biotherapeutics	375.99M

Market Cap Rankings